Volume | 14,051 |
|
|||||
News | - | ||||||
Day High | 2.88 | Low High |
|||||
Day Low | 2.74 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
MyMD Pharmaceuticals Inc | MYMD | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
2.85 | 2.74 | 2.88 | 2.81 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
157 | 14,051 | $ 2.80 | $ 39,403 | - | 2.00 - 70.50 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:18:13 | 1 | $ 2.842 | USD |
MyMD Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
6M | 2.09M | - | 0 | -8.22M | -3.93 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
MyMD Pharmaceuticals News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MYMD Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.50 | 2.9324 | 2.50 | 2.72 | 46,174 | 0.38 | 15.20% |
1 Month | 2.40 | 3.50 | 2.00 | 2.61 | 651,045 | 0.48 | 20.00% |
3 Months | 4.35 | 4.50 | 2.00 | 3.27 | 428,547 | -1.47 | -33.79% |
6 Months | 12.687 | 12.903 | 2.00 | 6.66 | 977,275 | -9.81 | -77.30% |
1 Year | 57.00 | 70.50 | 2.00 | 18.39 | 818,392 | -54.12 | -94.95% |
3 Years | 123.60 | 298.50 | 2.00 | 53.07 | 419,780 | -120.72 | -97.67% |
5 Years | 162.90 | 298.50 | 2.00 | 57.62 | 438,322 | -160.02 | -98.23% |
MyMD Pharmaceuticals Description
MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. |